GERMANTOWN, Md., Nov. 17 /PRNewswire/ -- Clongen Laboratories, LLC has been awarded a CLIA Certificate of Registration and is licensed in the State of Maryland to perform human clinical testing. The new laboratory facility offers a wide range of testing and research contract services to the scientific community. "Clongen Laboratories, LLC is well positioned to respond to the market needs and fill the high demand gaps in both the clinical testing as well as the biotechnology sectors. We are prepared to assist our neighboring communities and nationwide clients with their clinical as well as biotechnology testing needs," according to Dr. Ahmed Kilani, President and Founder of Clongen Laboratories, LLC.
"As more biotechnology products are moving through the pipeline and requiring lot clearance testing to obtain FDA approval, there is an increasing demand for biopharmaceutical testing and contract research laboratories. The diversity of the services we offer combined with the expert technical and regulatory knowledge we have are the main strengths in our organization," says Dr. Ahmed Kilani.
Dr. Kilani adds, "We are committed to our customers and strive to provide scientific support to a variety of scientific disciplines while keeping our price schedules competitive in order to build long-term relationships with our customers. Clongen Laboratories, LLC has several divisions and is poised for growth and expansion to satisfy the needs of its different service and research programs. One of our goals is to develop a universal proteomics microarray chip platform technology that can be utilized for the detection of infectious agents as well as protein targets of interest to investigators studying cytokines and other biological indicators."
"Biodefense has increasingly become a critical national priority and we are determined to use the resources at our disposal to build novel innovative technologies in the areas of rapid diagnostics of biological weapons as well as vaccine development. One of Clongen Laboratories' main areas of interest is the development of multiplex detection technologies for a myriad of human infectious agents using microarray technology and proteomics applications. A long term sustained effort will be made in order to contribute to scientific discovery in those two areas," says Dr. Ahmed Kilani. "Through collaborations with our colleagues in academic institutions and shared knowledge, we can speed the pace of discovery and bring our products to the market in a timely manner," adds Dr. Ahmed Kilani.
Clongen Laboratories, LLC is a biotechnology company that offers a wide range of clinical diagnostic services as well as research contracting and biopharmaceutical testing. We are CLIA-registered and licensed in the State of Maryland to perform human clinical testing. Our menu offerings include Chemistry, Microbiology and Immunology testing services. Clongen Laboratories, LLC's newly remodeled facility is conveniently located in Germantown, Maryland. Our dedicated scientists in the areas of Life Sciences Testing and Research are ready to meet with you to discuss your business needs. We are prepared to provide you with free phone consultation to respond to your questions. We pride ourselves in the highest quality products and competitive prices. For questions please call Dr. Ahmed Kilani at 301-916-0173 or Toll Free 877-CLONGEN (256-6436) or e-mail at akil@clongen.com
Clongen Laboratories, LLCCONTACT: Dr. Ahmed Kilani of Clongen Laboratories, LLC, +1-301-916-0173,or akil@clongen.com
Web site: http://www.clongen.com/
